BioXcel Therapeutics Inc.

07/16/2024 | Press release | Distributed by Public on 07/16/2024 11:02

BioXcel Therapeutics Announces Preliminary Estimated Unaudited Second Quarter Net Revenues from Sales of IGALMI™ (dexmedetomidine) Sublingual Film

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.